European Archives - Page 218 of 1060 - European Medical Journal

Who is More at Risk of Adverse Events After Coronary Procedures?

New study highlights the need for targeted anti-inflammatory treatments to reduce adverse cardiovascular events in high-risk patients.

Pre-eclampsia Linked to Congenital Heart Disease in Newborns

A significant association has been established between pre-eclampsia and congenital heart disease in offspring.

Key Interventions Show Potential to Reduce MRI Exam Delays

Introducing a few key interventions has the potential to reduce delays for MRI exams performed on patients under sedation or general anaesthesia.

MRI Sheds Light on Link Between Ovary Removal and Brain Function

Ovary removal prior to menopause has been shown to impact brain function later in life, according to recent research.

Gilead Symposium at AIDS 2024

As life expectancy for people with HIV has improved, healthcare needs have changed, and it is clear that success is more multifaceted…

New Urine Test Shows Promise for Early Detection of Bladder Cancer

EarlyTect BCD, a new urine-based test, shows high clinical performance in detecting bladder cancer among haematuria patients.

Monitoring Mental Health with Smart Devices and Passive Mobile Sensing

Loneliness can be continuously and objectively monitored using mobile and wearable technologies, according to a recent study

Enhanced Survival in Hepatocellular Carcinoma with Combined Therapy

A new trial reveals that combining TACE with sorafenib improves survival for patients with recurrent intermediate-stage hepatocellular carcinoma and positive microvascular invasion.

Continuous 3D Monitoring of Cerebral Blood Flow with Novel Wearable Patch

Non-invasive and continuous monitoring of cerebral blood flow is now possible with a conformal ultrasound patch designed for hands-free volumetric imaging

Comparing Quality of Life in Leukemia Treatments for Elderly Patients

A recent study reveals that older adults with acute myeloid leukaemia receiving hypomethylating agents enjoy significantly more home time compared to those on anthracycline-based therapy